Ignite Creation Date:
2025-12-24 @ 2:41 PM
Ignite Modification Date:
2025-12-26 @ 2:45 PM
Study NCT ID:
NCT04729959
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-10-20
First Post:
2021-01-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-03-11
Start Date Type:
ACTUAL
Primary Completion Date:
2025-06-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-09-04
Completion Date Type:
ESTIMATED
First Submit Date:
2021-01-28
First Submit QC Date:
None
Study First Post Date:
2021-01-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-17
Last Update Post Date:
2025-10-20
Last Update Post Date Type:
ESTIMATED